Spontaneous Cerebellar Hemorrhage in a Patient Taking Apixaban
Conclusions Recent FDA approval of several novel oral anticoagulants for use in patients with atrial fibrillation has resulted in a significant number of patients formerly treated with warfarin being switched to these newer agents. There remains a lack of clear guidelines for the management of hemorrhagic complications. This case report describes one management strategy and highlights the paucity of current evidence to support critical clinical decisions.
Source: Interdisciplinary Neurosurgery - Category: Neurosurgery Source Type: research
More News: Atrial Fibrillation | Brain | Cardiology | Coumadin | Craniotomy | Heart | Hemorrhagic Stroke | Neurology | Neurosurgery | Stroke | Warfarin